Smithkline Beecham Corp. v. Zenith Goldline Pharmaceuticals, Inc.
71 F. App'x 64
CourtCourt of Appeals for the Federal Circuit
DecidedAugust 6, 2003
DocketNos. 03-1142, 03-1143, 03-1144
StatusPublished
This text of 71 F. App'x 64 (Smithkline Beecham Corp. v. Zenith Goldline Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Smithkline Beecham Corp. v. Zenith Goldline Pharmaceuticals, Inc., 71 F. App'x 64 (Fed. Cir. 2003).
Opinion
Judgment
This CAUSE having been heard and considered, it is ORDERED and ADJUDGED:
AFFIRMED. See Fed. Cir. R. 36.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
Bluebook (online)
71 F. App'x 64, Counsel Stack Legal Research, https://law.counselstack.com/opinion/smithkline-beecham-corp-v-zenith-goldline-pharmaceuticals-inc-cafc-2003.